INVO Fertility Files 2024 Annual Report Amendment
Ticker: IVF · Form: 10-K/A · Filed: May 19, 2025 · CIK: 1417926
Sentiment: neutral
Topics: amendment, annual-report, company-name-change
TL;DR
INVO Fertility filed its amended 2024 10-K. Check for updates.
AI Summary
INVO Fertility, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as NAYA Biosciences, Inc. and INVO Bioscience, Inc., is incorporated in Nevada and headquartered in Sarasota, Florida. This filing was made on May 19, 2025.
Why It Matters
This amendment provides updated information for the fiscal year 2024, which is crucial for investors to assess the company's financial health and strategic direction.
Risk Assessment
Risk Level: low — This is a routine amendment to an annual report, not indicating new material adverse events.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2025-05-19 — Filing Date (The date the amendment was submitted to the SEC.)
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former company name
- INVO Bioscience, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 20250519 (date) — Filing date
- Sarasota, Florida (location) — Business address
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for the fiscal year ended December 31, 2024, for INVO Fertility, Inc.
What were INVO Fertility, Inc.'s previous names?
INVO Fertility, Inc. was formerly known as NAYA Biosciences, Inc. and INVO Bioscience, Inc.
When was this amendment filed?
This amendment was filed on May 19, 2025.
In which state is INVO Fertility, Inc. incorporated?
INVO Fertility, Inc. is incorporated in Nevada.
What is the business address of INVO Fertility, Inc.?
The business address of INVO Fertility, Inc. is 5582 Broadcast Court, Sarasota, Florida 34240.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on May 19, 2025 regarding INVO Fertility, Inc. (IVF).